Sam Altman's latest venture, Merge Labs, is pushing the boundaries of brain-computer interfaces (BCIs) with a bold new approach. The San Francisco-based startup, co-founded by Altman, has secured $252 million in seed funding and aims to revolutionize the field without relying on invasive surgery.
Altman's vision for BCIs – allowing humans to communicate with external devices using biological intelligence combined with AI – is shared among other prominent figures in Silicon Valley. In a 2017 blog post, Altman wrote about merging humans and machines, predicting that "the merge" has already started and will transform society. The CEO of OpenAI sees this as an opportunity to collaborate with Merge Labs on projects like scientific foundation models.
However, the BCI space is rapidly becoming saturated. Companies like Synchron, valued at $1 billion after a recent funding round, and Elon Musk's Neuralink are leading the charge. Neuralink has made significant strides in developing non-invasive BCI technology, which involves inserting threads into the brain to restore autonomy to people with paralysis.
In contrast, Merge Labs is focusing on achieving BCIs without surgery using entirely new technologies that connect with neurons using molecules instead of electrodes. This approach aims to leverage recent breakthroughs in biotechnology, hardware, neuroscience, and computing. The startup believes that these advancements make this goal possible and is working towards developing BCI devices that can transmit and receive information using deep-reaching modalities like ultrasound.
Merge Labs' emphasis on accessibility and safety sets it apart from other players in the market. With nearly 20 open roles available for computational neuroscientists, immunology experts, machine learning researchers, and more, the startup is poised to make a significant impact in the field of BCIs.
Altman's vision for BCIs – allowing humans to communicate with external devices using biological intelligence combined with AI – is shared among other prominent figures in Silicon Valley. In a 2017 blog post, Altman wrote about merging humans and machines, predicting that "the merge" has already started and will transform society. The CEO of OpenAI sees this as an opportunity to collaborate with Merge Labs on projects like scientific foundation models.
However, the BCI space is rapidly becoming saturated. Companies like Synchron, valued at $1 billion after a recent funding round, and Elon Musk's Neuralink are leading the charge. Neuralink has made significant strides in developing non-invasive BCI technology, which involves inserting threads into the brain to restore autonomy to people with paralysis.
In contrast, Merge Labs is focusing on achieving BCIs without surgery using entirely new technologies that connect with neurons using molecules instead of electrodes. This approach aims to leverage recent breakthroughs in biotechnology, hardware, neuroscience, and computing. The startup believes that these advancements make this goal possible and is working towards developing BCI devices that can transmit and receive information using deep-reaching modalities like ultrasound.
Merge Labs' emphasis on accessibility and safety sets it apart from other players in the market. With nearly 20 open roles available for computational neuroscientists, immunology experts, machine learning researchers, and more, the startup is poised to make a significant impact in the field of BCIs.
. It's like, super cool that they're pushing the boundaries without surgery 
. I mean, who needs electrodes when you can use molecules to connect with neurons? 
That tech sounds next-level, and it's awesome that they're emphasizing accessibility and safety. It's a big deal for people with paralysis or other conditions where invasive surgeries aren't an option 
. And the fact that they're collab-ing with OpenAI on projects is like, totally mind-blowing 
.
. I mean, who wouldn't want to control devices with just their thoughts? 
But seriously, it's exciting to see Sam Altman pushing the boundaries like this. The fact that they're focusing on non-invasive tech is a major plus – no more poking around in people's brains! 
. The BCI space is getting crowded, but if anyone can pull off something revolutionary, it's them 
.
or controlling robots with just a thought 
. I'm curious to see how they'll balance accessibility and safety while still pushing the boundaries of what's possible - it's a tough space to navigate. Anyone think we'll see major breakthroughs in BCI tech within the next 5-7 years?
Moreover, their emphasis on accessibility and safety is a major plus – we need more companies prioritizing human well-being in tech development 
I'm curious to see how their collaboration with OpenAI will play out and if they can really deliver on their vision of "the merge" 
. They're taking a different approach to BCIs by using molecules instead of electrodes, which sounds like it could be way safer and more accessible for people who want to use them. It's cool that they're already attracting top talent from various fields, that’s a good sign. But, I don’t know if they can compete with the likes of Neuralink and Synchron... their tech seems pretty advanced but BCI space is getting crowded 
also what's the deal with using molecules instead of electrodes? sounds super sciency 
It's crazy that they're using molecules to connect with neurons instead of electrodes. That technology is still super new and might just give them an edge over Neuralink 
Their use of molecules instead of electrodes is genius, and the fact that they're working with biotechnology, hardware, neuroscience, and computing experts makes me think this thing could actually work 
. I mean, who wants BCIs that are only available to those with deep pockets? 
they've got the funding, the team, the tech... why does merge labs need to be the one? 
plus, isn't it kinda scary that we're already messing around with our brains using threads and electrodes? 
shouldn't we be cautious about this kind of tech? 
plus, $252 million in seed funding is no joke 
then we'll see some wild advancements in healthcare and tech 
. And the fact that they've got 20 open roles available for some of the smartest minds out there? That's a recruitment dream come true 
! I'm curious to see how this plays out and what kind of impact Merge Labs will make in the BCI space 
.